Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
NGM Biopharmaceuticals Inc banner
N

NGM Biopharmaceuticals Inc
F:0IK

Watchlist Manager
NGM Biopharmaceuticals Inc
F:0IK
Watchlist
Price: 3.19 EUR 3.91%
Market Cap: €266.2m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
Jun 30, 2025 326m
Dec 31, 2024 331.4m
Jun 30, 2024 296.8m
Dec 31, 2023 265.4m
Liabilities
+
Jun 30, 2025 107.2m
Dec 31, 2024 121m
Jun 30, 2024 95.2m
Dec 31, 2023 106.1m
Equity
+
Jun 30, 2025 218.8m
Dec 31, 2024 210.4m
Jun 30, 2024 201.6m
Dec 31, 2023 159.2m

Balance Sheet Decomposition
NGM Biopharmaceuticals Inc

Balance Sheet
NGM Biopharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
34
33
42
40
Cash Equivalents
34
33
42
40
Total Receivables
16
23
39
39
Accounts Receivables
15
21
30
31
Other Receivables
1
2
9
8
Inventory
41
48
108
157
Other Current Assets
5
3
3
4
Total Current Assets
96
107
192
245
PP&E Net
5
5
12
11
PP&E Gross
5
5
12
11
Accumulated Depreciation
4
6
8
11
Intangible Assets
26
36
59
73
Other Long-Term Assets
0
0
3
2
Total Assets
127
N/A
147
+16%
265
+80%
331
+25%
Liabilities
Accounts Payable
15
18
62
179
Accrued Liabilities
4
4
6
8
Short-Term Debt
0
0
0
0
Current Portion of Long-Term Debt
0
0
1
1
Other Current Liabilities
4
6
13
6
Total Current Liabilities
23
28
83
98
Long-Term Debt
2
1
6
5
Deferred Income Tax
6
8
10
10
Other Liabilities
0
4
7
8
Total Liabilities
31
N/A
40
+29%
106
+164%
121
+14%
Equity
Common Stock
45
45
65
1
Retained Earnings
51
62
94
177
Additional Paid In Capital
0
0
0
32
Total Equity
96
N/A
107
+12%
159
+49%
210
+32%
Total Liabilities & Equity
127
N/A
147
+16%
265
+80%
331
+25%
Shares Outstanding
Common Shares Outstanding
193
193
193
193

See Also

Summary
0IK intrinsic value, competitors valuation, and company profile.
DCF Valuation
0IK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0IK stock valuation using valuation multiples.
Wall Street Estimates
0IK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0IK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 318,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.